{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Biodexa Pharmaceuticals plc"},"Symbol":{"label":"Symbol","value":"BDRX"},"Address":{"label":"Address","value":"1 CASPIAN POINT,CASPIAN WAY, CARDIFF, CF10 4DQ, United Kingdom"},"Phone":{"label":"Phone","value":"+44 2920480180"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"Europe"},"CompanyDescription":{"label":"Company Description","value":"Biodexa Pharmaceuticals PLC is a United Kingdom-based drug delivery technology company. The Company is focused on improving the bio-delivery and bio-distribution of medicines. Its technologies include Biodexa Pharmaceuticals Q-Sphera, MidaCore and MidaSolve. Biodexa Pharmaceuticals Q-Sphera technology focuses on long acting injectables using proprietary 3D printing technology that encapsulates medicines into bioresorbable polymer microspheres with precision characteristics. MidaCore technology platform uses ultra-small gold nanoparticle (GNP) drug conjugates. MidaSolve Nano Inclusion technology solubilizes molecules that have minimal solubility at biological potential of Hydrogen (pH) extending available routes of administration, including direct-to-tumor delivery. It has a pipeline of approximately eight earlier stage programs, MTX110 (Brain Cancer in Children (DIPG)), MTX110 (Medulloblastoma), MTX110 (Glioblastoma), MTX114 (Psoriasis), MTD211 (Schizophrenia, MDD) and others."},"CompanyUrl":{"label":"Company Url","value":"https://www.biodexapharma.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Dan Palmer","title":"Vice President-Technology"},{"name":"Dmitry Zamoryakhin","title":"Chief Scientific Officer"},{"name":"Nicola Tuckwell","title":"Vice President-Clinical Operations"},{"name":"Stephen Anthony Stamp","title":"Chief Executive Officer, CFO, Secretary & Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}